# Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia

> **NCT00111371** · PHASE4 · UNKNOWN · sponsor: **University Hospital Muenster** · enrollment: 100 (estimated)

## Conditions studied

- Dyslexia

## Interventions

- **DRUG:** Levodopa

## Key facts

- **NCT ID:** NCT00111371
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2015-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00111371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00111371, "Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00111371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*